Cargando…

Rapid and effective response of the R222Q SCN5A to quinidine treatment in a patient with Purkinje-related ventricular arrhythmia and familial dilated cardiomyopathy: a case report

BACKGROUND: Mutations of the SCN5A gene are reported in 2-4% of patients with dilated cardiomyopathy (DCM). In such cases, DCM is associated with different rhythm disturbances such as the multifocal ectopic Purkinje-related premature contractions and atrial fibrillation. Arrhythmia often occurs at a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zakrzewska-Koperska, Joanna, Franaszczyk, Maria, Bilińska, Zofia, Truszkowska, Grażyna, Karczmarz, Małgorzata, Szumowski, Łukasz, Zieliński, Tomasz, Płoski, Rafał, Bilińska, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989373/ https://www.ncbi.nlm.nih.gov/pubmed/29871609 http://dx.doi.org/10.1186/s12881-018-0599-4

Ejemplares similares

A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation
por: Zakrzewska‐Koperska, Joanna, et al.
Publicado: (2020)

A Novel DSP Truncating Variant in a Family with Episodic Myocardial Injury in the Course of Arrhythmogenic Cardiomyopathy—A Possible Role of a Low Penetrance NLRP3 Variant
por: Chmielewski, Przemysław, et al.
Publicado: (2020)

Titin-Related Dilated Cardiomyopathy: The Clinical Trajectory and the Role of Circulating Biomarkers in the Clinical Assessment
por: Chmielewski, Przemysław, et al.
Publicado: (2021)

A different background of arrhythmia in siblings with a positive family history of sudden death at young age
por: Stępień‐Wojno, Małgorzata, et al.
Publicado: (2019)

Homozygous truncating mutation in NRAP gene identified by whole exome sequencing in a patient with dilated cardiomyopathy
por: Truszkowska, Grażyna T., et al.
Publicado: (2017)

Analysis of De Novo Mutations in Sporadic Cardiomyopathies Emphasizes Their Clinical Relevance and Points to Novel Candidate Genes
por: Franaszczyk, Maria, et al.
Publicado: (2020)

A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations
por: Truszkowska, Grażyna T, et al.
Publicado: (2015)

Can Circulating Cardiac Biomarkers Be Helpful in the Assessment of LMNA Mutation Carriers?
por: Chmielewski, Przemyslaw, et al.
Publicado: (2020)

Titin Truncating Variants in Dilated Cardiomyopathy – Prevalence and Genotype-Phenotype Correlations
por: Franaszczyk, Maria, et al.
Publicado: (2017)

Tripeptidyl Peptidase 1 (TPP1) Deficiency in a 36-Year-Old Patient with Cerebellar-Extrapyramidal Syndrome and Dilated Cardiomyopathy
por: Ługowska, Agnieszka, et al.
Publicado: (2021)

Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections
por: Ponińska, Joanna Kinga, et al.
Publicado: (2022)

The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation
por: Franaszczyk, Maria, et al.
Publicado: (2014)

A novel truncating variant in the LAMP2 gene in a young woman with hypertrophic cardiomyopathy and variable clinical course in the family
por: Michalak, Ewa, et al.
Publicado: (2019)

Severe Course of Peripartum Cardiomyopathy and Subsequent Recovery in a Patient with a Novel TTN Gene-Truncating Mutation
por: Kryczka, Karolina E., et al.
Publicado: (2018)

Double Heterozygous Pathogenic Variants in the LOX and PKD1 Genes in a 5-Year-Old Patient with Thoracic Aortic Aneurysm and Polycystic Kidney Disease
por: Ponińska, Joanna Kinga, et al.
Publicado: (2023)

Variable clinical presentation of glycogen storage disease type IV: from severe hepatosplenomegaly to cardiac insufficiency. Some discrepancies in genetic and biochemical abnormalities
por: Szymańska, Edyta, et al.
Publicado: (2017)

Combination of low-dose quinidine and verapamil for multifocal ectopic Purkinje-related premature contractions in a patient with SCN5A mutation
por: Enokizono, Kei, et al.
Publicado: (2023)

LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies
por: Saj, Michal, et al.
Publicado: (2013)

Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome
por: Halperin, Laura, et al.
Publicado: (2018)

The Gain-of-Function R222S Variant in Scn11a Contributes to Visceral Hyperalgesia and Intestinal Dysmotility in Scn11a(R222S/R222S) Mice
por: Zhao, Chenyu, et al.
Publicado: (2022)

The Price of Quinidine
Publicado: (1922)

A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the RYR2 Gene
por: Stępień-Wojno, Małgorzata, et al.
Publicado: (2020)

Safety of a simplified electrophysiological method of transseptal puncture. A single center’s experience
por: Łodyga, Małgorzata, et al.
Publicado: (2018)

Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism
por: Bilinska, Katarzyna, et al.
Publicado: (2020)

Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis
por: Gawor, Monika, et al.
Publicado: (2022)

Association between Variants on Chromosome 4q25, 16q22 and 1q21 and Atrial Fibrillation in the Polish Population
por: Kiliszek, Marek, et al.
Publicado: (2011)

Frequent His‐Purkinje discharges with longitudinal dissociation in a case with multiple premature ventricular contractions suppressed by co‐treatment with verapamil and quinidine
por: Suzuki, Keisuke, et al.
Publicado: (2022)

Social Deficits and Cerebellar Degeneration in Purkinje Cell Scn8a Knockout Mice
por: Yang, Xiaofan, et al.
Publicado: (2022)

Quinidine for Brugada syndrome: Panacea or poison?
por: Hai, Jo-Jo, et al.
Publicado: (2016)

Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor
por: Butowt, Rafal, et al.
Publicado: (2020)

Expression of the ACE2 virus entry protein in the nervus terminalis reveals the potential for an alternative route to brain infection in COVID-19
por: Bilinska, Katarzyna, et al.
Publicado: (2021)

Expression of the ACE2 Virus Entry Protein in the Nervus Terminalis Reveals the Potential for an Alternative Route to Brain Infection in COVID-19
por: Bilinska, Katarzyna, et al.
Publicado: (2021)

Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019( )
por: Butowt, Rafal, et al.
Publicado: (2022)

Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms
por: Butowt, Rafal, et al.
Publicado: (2023)

Mouse Models of SCN5A-Related Cardiac Arrhythmias
por: Derangeon, Mickael, et al.
Publicado: (2012)

The Purkinje–myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT
por: Blackwell, Daniel J., et al.
Publicado: (2022)

The Therapeutic Value of Quinidine Sulphate in Auricular Fibrillation
por: Ritchie, W. T.
Publicado: (1922)

Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021)

Variants in the SCN5A Promoter Associated With Various Arrhythmia Phenotypes
por: Yagihara, Nobue, et al.
Publicado: (2016)

Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3
por: Iyer, Vivek, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sdfskhuiga1qr4ashp5c6pvmes